Rankings
▼
Calendar
TKNO (Alpha Teknova, Inc.) Stock Financials & Earnings | Market Cap Arena
TKNO
Alpha Teknova, Inc.
Mkt Cap
$133M
Healthcare
·
Drug Manufacturers - Specialty & Generic
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$41M
Net Income (TTM)
-$17M
EPS (TTM)
-$0.32
Free Cash Flow (TTM)
-$10M
Gross Margin
33.2%
Op. Margin
-41.9%
Net Margin
-42.6%
FCF Margin
-23.7%
P/S Ratio (TTM)
3.3x
P/E Ratio (TTM)
—
YoY Rev Growth
+7.4%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$9M
$2M
-$9M
Q2 23
$12M
$5M
-$7M
Q3 23
$8M
$1M
-$9M
Q4 23
$8M
$1M
-$11M
Q1 24
$9M
$2M
-$8M
Q2 24
$10M
$3M
-$5M
Q3 24
$10M
$90K
-$7M
Q4 24
$9M
$2M
-$6M
Q1 25
$10M
$3M
-$5M
Q2 25
$10M
$4M
-$3M
Q3 25
$10M
$3M
-$4M
Q4 25
$10M
$3M
-$5M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
3.4x
—
Q2 23
3.4x
—
Q3 23
3.6x
—
Q4 23
3.6x
—
Q1 24
3.6x
—
Q2 24
3.8x
—
Q3 24
3.7x
—
Q4 24
3.5x
—
Q1 25
3.5x
—
Q2 25
3.4x
—
Q3 25
3.3x
—
Q4 25
3.3x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$8M
-$12M
Q2 23
-$4M
-$6M
Q3 23
-$4M
-$5M
Q4 23
-$3M
-$3M
Q1 24
-$7M
-$7M
Q2 24
-$3M
-$3M
Q3 24
-$2M
-$2M
Q4 24
-$936K
-$2M
Q1 25
-$4M
-$4M
Q2 25
-$2M
-$2M
Q3 25
-$2M
-$2M
Q4 25
-$362K
-$710K
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$4M
Q2 23
$2M
Q3 23
$972K
Q4 23
$312K
Q1 24
$112K
Q2 24
$115K
Q3 24
$331K
Q4 24
$567K
Q1 25
$206K
Q2 25
$207K
Q3 25
$387K
Q4 25
$348K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-18.2%
+6.3%
Q2 23
-1.4%
+1.1%
Q3 23
-23.6%
-49.7%
Q4 23
-0.3%
-15.4%
Q1 24
+1.9%
-4.4%
Q2 24
-16.6%
-20.6%
Q3 24
+17.2%
+0.5%
Q4 24
+17.8%
-20.5%
Q1 25
+5.4%
-14.6%
Q2 25
+7.0%
-7.1%
Q3 25
+9.2%
-14.9%
Q4 25
+7.8%
-2.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$0
0.0%
Q2 23
$0
0.0%
Q3 23
$0
0.0%
Q4 23
$1M
13.0%
Q1 24
$1M
14.1%
Q2 24
$0
0.0%
Q3 24
$760K
7.9%
Q4 24
$766K
8.3%
Q1 25
$852K
8.7%
Q2 25
$950K
9.2%
Q3 25
$0
0.0%
Q4 25
$777K
7.8%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$1M
$7M
$2M
Q2 23
$1M
$6M
$2M
Q3 23
$1M
$6M
$2M
Q4 23
$1M
$6M
$2M
Q1 24
$860K
$7M
$2M
Q2 24
$678K
$5M
$1M
Q3 24
$627K
$5M
$2M
Q4 24
$594K
$5M
$2M
Q1 25
$552K
$5M
$2M
Q2 25
$581K
$5M
$2M
Q3 25
$542K
$5M
$2M
Q4 25
$522K
$5M
$2M
marketcaparena.com
Revenue Segments
Clinical Solutions
Lab Essentials
Other Product
Quarter
Clinical Solutions
Lab Essentials
Other Product
Q1 23
$2M
$7M
$255K
Q2 23
$4M
$8M
$293K
Q3 23
$597K
$7M
$298K
Q4 23
$879K
$7M
$300K
Q1 24
$2M
$7M
$306K
Q2 24
$2M
$8M
$411K
Q3 24
$2M
$7M
$451K
Q4 24
$2M
$7M
$597K
Q1 25
$1M
$8M
$516K
Q2 25
$2M
$8M
$435K
Q3 25
$2M
$8M
$440K
Q4 25
$3M
$7M
$435K
marketcaparena.com
Revenue by Geography
Non-US
United States
Quarter
Non-US
United States
Q1 23
$395K
$9M
Q2 23
$452K
$11M
Q3 23
$342K
$8M
Q4 23
$495K
$7M
Q1 24
$420K
$9M
Q2 24
$386K
$9M
Q3 24
$519K
$9M
Q4 24
$501K
$9M
Q1 25
$523K
$9M
Q2 25
$510K
$10M
Q3 25
$622K
$10M
Q4 25
$616K
$9M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$30M
$0
$30M
Q2 23
$24M
$0
$24M
Q3 23
$32M
$0
$32M
Q4 23
$28M
$0
$28M
Q1 24
$22M
$0
$22M
Q2 24
$19M
$0
$19M
Q3 24
$6M
$26M
$32M
Q4 24
$4M
$27M
$30M
Q1 25
$3M
$23M
$26M
Q2 25
$3M
$21M
$24M
Q3 25
$3M
$0
$3M
Q4 25
$6M
$0
$6M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
28M
+0.1%
Q2 23
28M
+0.3%
Q3 23
30M
+6.0%
Q4 23
41M
+36.0%
Q1 24
41M
+0.1%
Q2 24
41M
+0.1%
Q3 24
45M
+9.0%
Q4 24
53M
+19.9%
Q1 25
53M
+0.1%
Q2 25
53M
+0.1%
Q3 25
54M
+0.1%
Q4 25
54M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 19
—
—
FY 20
—
—
FY 21
$156K
237
FY 22
$143K
290
FY 23
$174K
211
FY 24
$218K
173
FY 25
$256K
158
marketcaparena.com